<DOC>
	<DOCNO>NCT02441491</DOCNO>
	<brief_summary>ROHHAD ( rapid onset obesity , hypothalamic dysfunction , hypoventilation , autonomic dysregulation ) syndrome rare pediatric disorder associate cancer call neuroblastoma presume driven attack immune system specific area brain . Patients develop severe symptom often succumb disease . Based researcher ' experience investigator conduct clinical trial study intensive immunosuppression high-dose cyclophosphamide patient . In addition describe symptomatic improvement , investigator ' trial seek define objective marker disease activity .</brief_summary>
	<brief_title>Treatment Rapid Onset Obesity , Hypoventilation , Hypothalamic Dysfunction , Autonomic Dysregulation ( ROHHAD )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Diagnosis ROHHAD syndrome confirm two physician . Any symptomatic improvement response course rituximab ( five weekly dos ) assess parent and/or treat physician Normal brain MRI Cared home family Patients require bilevel positive airway pressure ( BiPAP ) support eligible Negative pregnancy test post pubertal female patient Cardiac ejection fraction &lt; 40 % shorten fraction &lt; 20 % . Inadequate pulmonary function , i.e . force vital capacity force expiratory volume one second &lt; 50 % predict child great 8 year age , oxygen saturation &lt; 93 % pulse oximetry young child . Ventilator dependent Known chromosomal abnormality Active cancer diagnosis . Neuroblastoma require follow eligible . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>